Katsuhiko Iwasaki

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Meiji Pharmaceutical University(Current)

Katsuhiko Iwasaki is an author at Meiji Pharmaceutical University specializing in conventional synthetic disease-modifying antirheumatic drugs, nonsteroidal anti-inflammatory drug safety, and internal medicine.

Publications per year

2022–2023

Publications

Working Conditions, Work Productivity, Quality of Life, and Depressive Symptoms in Undiagnosed Adults with and without Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms During the COVID-19 Pandemic

Toru Nakai, Toshinaga Tsuji, Hiroshi Tsuda et al. · Neuropsychiatric Disease and Treatment · 2022 · 12 citations · Full text

Health Professions, Health Sciences, Psychiatry +17

Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database

Masayoshi Harigai, Takao Fujii, Ryoko Sakai et al. · Modern Rheumatology · 2023 · 10 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

1–2 of 2